Company profile
MAXCYTE, INC.
NASDAQ:MXCTBiotechnology: Commercial Physical & Biological Resarch
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03608618 | phase1 | terminated | 2018-08-27 | 2021-02-11 | MaxCyte, Inc. | Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma |
FDA applications (0)
No records yet.